Aptose Biosciences Inc (APTO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

251 CONSUMERS ROAD TORONTO, ONTARIO, CANADA M2J 4R3

Lorus Therapeutics is a biopharmaceutical company. Co. is engaged in the discovery, research and development of novel anticancer therapies with a safety profile. Co. has worked to establish a marketable anticancer product pipeline, with products in various stages of development ranging from discovery and pre-clinical to preparation for initiation of a Phase III clinical trial. Co. is considered to be in the development stage.

Data based on most recent fiscal year report
Market Cap453.291 Million Shares Outstanding71.61 Million Avg Volume672.314 Thousand
1-Yr BETA vs S&P TR1.0 Current Ratio5.91 Quick Ratio5.91
View SEC Filings from APTO instead.

View recent insider trading info

Funds Holding APTO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APTO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.4 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RICE WILLIAM G. CHAIR, PRESIDENT & CEO

  • Officer
  • Director
466,414 2020-03-25 5

BURGER DENIS R

  • Director
0 2020-03-13 3

LOEWY CAROLINE M

  • Director
0 2020-03-13 3

PLATZER ERICH

  • Director
0 2020-03-11 2

VINCENT MARK D.

  • Director
0 2020-03-11 3

WHITEHEAD WARREN

  • Director
0 2020-03-11 3

ASHE CAROL GAIL

  • Director
0 2020-03-11 2

CHOW GREGORY K. EXECUTIVE VP & CFO

  • Officer
359,514 2020-03-10 3

MARANGO JOTIN SENIOR VP, CHIEF BUS. OFFICER

  • Officer
200,000 2020-03-10 4

BEJAR RAFAEL SR. VP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-31 3

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RICE WILLIAM G. - Director - Officer CHAIR, PRESIDENT & CEO

2020-03-25 P 3,400 $5.82 a 466,414 466,414.00 direct

LOEWY CAROLINE M - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

WHITEHEAD WARREN - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

BURGER DENIS R - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

VINCENT MARK D. - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

PLATZER ERICH - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

LOEWY CAROLINE M - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

ASHE CAROL GAIL - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

BURGER DENIS R - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

VINCENT MARK D. - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

WHITEHEAD WARREN - Director

2020-03-11 A 50,000 a 50,000 0.00 direct

RICE WILLIAM G. - Director - Officer CHAIR, PRESIDENT & CEO

2020-03-10 A 300,000 a 463,014 463,014.00 direct

MARANGO JOTIN - Officer SENIOR VP, CHIEF BUS. OFFICER

2020-03-10 A 120,000 a 200,000 200,000.00 direct

CHOW GREGORY K. - Officer EXECUTIVE VP & CFO

2020-03-10 A 225,000 a 359,514 359,514.00 direct

Elevate your investments